#United States #Richmond #Slope #Clinical Trials #Velocity Clinical Research

Slope and Velocity Clinical Research Partner to Streamline Clinical Inventory Management

In a groundbreaking alliance, Slope, recognized as the leading vendor-neutral software provider, has teamed up with Velocity Clinical Research, the largest organization of integrated clinical research sites globally. This partnership aims to implement Slope's advanced inventory management solutions across more than 70 Velocity sites located in the U.S. and Europe. The collaboration is set to enhance operational efficiency and inform study feasibility decisions in clinical trials.

Transforming Clinical Research Operations

By integrating Slope's comprehensive system, Velocity aims to revolutionize how clinical inventory and biospecimens are managed. With over 2,400 research sites worldwide already utilizing Slope’s solutions in more than 24 countries, the partnership bolsters their operational capabilities significantly. The initiative stems from prior successes, as Slope had already seen adoption at 31 of Velocity’s sites before the formal partnership, demonstrating the platform's usability and utility.

Nicholas Spittal, the Chief Operations Officer at Velocity Clinical Research, expressed confidence in the software's effectiveness. He stated, "The grassroots adoption gave confidence that Slope is easy to use and already providing added value for running efficient sites. With real-time visibility into study equipment and clinical supplies across all of Velocity, we can now make faster, better-informed decisions about operational readiness, prioritization, and allocation of work."

This motive resonates with Slope’s founding principles, as its co-founder and CEO, Rust Felix, emphasized the importance of supporting research sites in streamlining their operations. "Research sites are on the front lines of clinical trials, playing the most challenging role in bringing new therapies to patients. As we assist them in functioning more efficiently and minimizing administrative burdens, the entire clinical research ecosystem benefits,” he said.

Driving Feasibility Decisions and Efficiency

With the implementation of Slope's system, Velocity can gather critical information regarding study equipment and supplies, facilitating swifter decision-making processes concerning operational readiness. This capability is crucial in a highly competitive landscape where site selection is paramount for clinical trials.

The relationship between Slope and Velocity promises considerable operational advantages. As they scale their efforts, both organizations predict that improved processes will lead to reduced study initiation durations, diminished supply waste, and enhanced competitive edges for Velocity’s sites. These efficiencies ultimately translate into an optimized clinical research environment, benefiting all stakeholders involved.

Conclusion

The partnership between Slope and Velocity Clinical Research marks a vital step toward transforming inventory management practices in clinical research. By leveraging Slope's innovative technology, Velocity is set to redefine its operational framework, facilitating faster, more informed decisions that increase overall productivity. This venture aligns with the broader commitment to bring cutting-edge therapies to patients timely and effectively. For more information, visit Slope and Velocity Clinical Research.